DCM
EBACW

Difesa Capital Management’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

Difesa Capital Management’s Portfolio EBACW Stock Details EBACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-14,159
Closed -$1K – 295
2022
Q3 		$1K Hold
14,159
– – ﹤0.01% 230
2022
Q2 		$2K Hold
14,159
– – ﹤0.01% 240
2022
Q1 		$3K Hold
14,159
– – ﹤0.01% 250
2021
Q4 		$8K Buy
+14,159
New +$9.05K 0.01% 223

Other funds holding EBACW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
TCSAM
Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 20.06% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.4% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Difesa Capital Management's EBACW Position: Q4 2022 in Review

Difesa Capital Management sold out of European Biotech Acquisition Corp. Warrant (EBACW) in Q4 2022, closing a stake of 14,159 shares — an estimated $1K sold.

Difesa Capital Management first reported a position in EBACW in Q4 2021 and held it in 4 quarters. The position peaked at $8K in Q4 2021. 32 funds tracked by Wall St. Rank hold EBACW as of Q4 2022.

  • Difesa Capital Management reported no remaining European Biotech Acquisition Corp. Warrant position as of Q4 2022 after selling out during the quarter.
  • Difesa Capital Management sold 14,159 European Biotech Acquisition Corp. Warrant shares in Q4 2022, an estimated $1K.
  • Difesa Capital Management first reported a position in European Biotech Acquisition Corp. Warrant in Q4 2021 and held it in 4 quarters.
  • Difesa Capital Management's European Biotech Acquisition Corp. Warrant position peaked at $8K in Q4 2021.
  • 32 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Warrant as of Q4 2022.

Based on Difesa Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.